VISO Therapeutics Inc.

Biotechnology company · Chicago, Illinois, United States

VISO Therapeutics Inc. is a biotechnology company headquartered in Chicago, Illinois, United States. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $300,889 in total, most recently in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

VISO Therapeutics at a glance

Typebiotechnology company

HeadquartersChicago, Illinois, United States

Employees (self-reported, 2022)2

What does VISO Therapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $300,889 in total (2022). NIH funding came from the National Eye Institute.

Frequently asked questions about VISO Therapeutics

Where is VISO Therapeutics headquartered?

VISO Therapeutics Inc. is headquartered in Chicago, Illinois, United States.

What does VISO Therapeutics do?

VISO Therapeutics Inc. is a biotechnology company.

Similar companies

Metame Health Inc.Chicago, Illinois, United States
Synapticure, Inc.Chicago, Illinois, United States
BiomeSense, Inc.Chicago, Illinois, United States
Inomagen Therapeutics, Inc.Chicago, Illinois, United States
Nuago Therapeutics, Inc.Chicago, Illinois, United States
Advanced Cooling Therapy, Inc.Chicago, Illinois, United States
Diagnostic Photonics, Inc.Chicago, Illinois, United States
Microsensor Labs, LLCChicago, Illinois, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences